Predicting drug sensitivity and resistance
نویسندگان
چکیده
منابع مشابه
Predicting PARP inhibitor sensitivity and resistance
A healthy diet rich in fruits and vegetables is an important part of a healthy lifestyle. Whereas epidemiological data sometimes fail to provide proof of this concept, molecular evidence is accumulating that clearly shows both preventive as well as therapeutic effects of compounds from natural origins. in the paper of Guido Kroemer's group about pro-autophagic polyphenols and their inhibitory e...
متن کاملPredicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.
For analysis of multidrug resistance, a major barrier to effective cancer chemotherapy, we profiled mRNA expression of the 48 known human ABC transporters in 60 diverse cancer cell lines (the NCI-60) used by the National Cancer Institute to screen for anticancer activity. The use of real-time RT-PCR avoided artifacts commonly encountered with microarray technologies. By correlating the results ...
متن کاملPredicting HIV drug resistance with neural networks
MOTIVATION Drug resistance is a very important factor influencing the failure of current HIV therapies. The ability to predict the drug resistance of HIV protease mutants may be useful in developing more effective and longer lasting treatment regimens. METHODS The HIV resistance is predicted to two current protease inhibitors, Indinavir and Saquinavir. The problem was approached from two pers...
متن کاملThe Role of Self-Concealment and Alexithymia in Predicting Resistance to Change of Drug Users
Introduction: Addiction is a complex disease characterized by compulsive behaviors, irresistible temptations, drug behaviors, and persistent consumption, even when there are many negative consequences for the individual. Objective: The purpose of this study was to determine the role of self-concealment and alexithymia in predicting resistance to change of drug users. Material and Methods: This ...
متن کاملPredicting outcomes and drug resistance with new standardised treatment.
In their hypothetical cohorts OXLADE et al. [1] predicted significant public-health benefits by changing from the 8-month to the 6-month (2HRZE/6HE to 2HRZE/4HR; where H5isoniazid, R5rifampicin, Z5pyrazinamide and E5ethambutol) regimen. Data from 2008 on drug-resistance surveillance from five World Health Organization (WHO) regions, i.e. Africa (Botswana), Western Pacific (China), Africa (Mozam...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Cell
سال: 2004
ISSN: 1535-6108
DOI: 10.1016/j.ccr.2004.06.026